Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 3/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 4/20 | 0.35 |
| ▸ | RXRB | P28702 | 4/20 | 0.35 |
| ▸ | TACR1 | P25103 | 6/20 | 0.34 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26529015 | 0.99 | ICMT (0.36) | ICMTKIF11RXRARXRBTACR1 | |
| SCHEMBL26528835 | 0.95 | PTPN5 (0.35) | ICMTKIF11RXRARXRBPTPN5 | |
| SCHEMBL26529498 | 0.94 | ICMT (0.36) | ICMTKIF11RXRARXRBTACR1 | |
| SCHEMBL26528840 | 0.94 | ICMT (0.35) | ICMTKIF11RXRARXRBTACR1 | |
| SCHEMBL26528839 | 0.93 | ICMT (0.34) | ICMTKIF11RXRARXRBTACR1 | |
| SCHEMBL26528984 | 0.93 | ICMT (0.37) | ICMTRXRARXRBPTPN5RXRG | |
| SCHEMBL26528970 | 0.92 | RXRA (0.37) | ICMTKIF11RXRARXRBTACR1 | |
| SCHEMBL26534128 | 0.92 | ICMT (0.41) | ICMTKIF11RXRARXRBTACR1 | |
| SCHEMBL26529348 | 0.91 | ICMT (0.36) | ICMTRXRARXRBRXRG | |
| SCHEMBL26534175 | 0.90 | ICMT (0.42) | ICMTKIF11RXRARXRBTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | ICMT 36/4885KIF11 3651/4885RXRA 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.